查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1592695

胜肽 API 市場 - 2024-2034 年全球產業分析、規模、佔有率、成長、趨勢和預測

Peptide API Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 204 Pages | 商品交期: 2-10個工作天內

價格

胜肽 API 市場 - 報告範圍

TMR 關於全球胜肽 API 市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2024 年至 2034 年預測期內市場指標的寶貴見解。 ，考慮2024年為基準年，2034年為預測年。報告中也提供了2024年至2034年全球胜肽原料藥市場的年複合成長率（CAGR%）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解胜肽 API 市場。

市場概況
2023年市場價值 92 億美元
2034 年市場價值 942 億美元
複合年成長率 22.4%

該報告深入探討了全球胜肽原料藥市場的競爭格局。全球胜肽原料藥市場的主要參與者已經確定，並且每位參與者的各種屬性都已被描述。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球胜肽 API 市場參與者的屬性。

目錄

第1章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概覽

  • 介紹
  • 概述
  • 市場動態
  • 2020-2034 年全球市場分析與預測

第 5 章：關鍵見解

  • 主要國家/地區糖尿病和肥胖流行病學
  • GLP-1 受體激動劑治療產業的最新技術進展
  • 胰島素治療產業的最新技術進步
  • GLP-1 受體激動劑治療藥物定價趨勢
  • 胰島素治療定價趨勢
  • 臨床試驗分析

第 6 章：全球市場分析與預測：依藥物類別

  • 簡介與定義
  • 主要發現/進展
  • 2020-2034 年按藥物類別分類的市場價值、數量和患者人數預測
    • GLP-1 受體激動劑
    • 胰島素
    • 其他胜肽類
  • 按藥物類別分類的市場吸引力

第 7 章：全球市場分析與預測：依產品類型

  • 簡介與定義
  • 主要發現/進展
  • 2020-2034 年按產品類型分類的市場價值、數量和患者人數預測
    • GLP-1受體激動劑口服製劑
    • GLP-1受體激動劑注射劑
    • 胰島素注射劑
    • 其他胜肽
  • 按產品類型分類的市場吸引力

第 8 章：全球市場分析與預測：按管理途徑

  • 簡介與定義
  • 主要發現/進展
  • 2020-2034 年按給藥途徑分類的市場價值、數量和患者人數預測
    • 口服
    • 注射用
  • 按給藥途徑分類的市場吸引力

第 9 章：全球市場分析與預測：按應用分類

  • 簡介與定義
  • 主要發現/進展
  • 2020-2034 年按應用分類的市場價值、數量和患者人數預測
    • 2 型糖尿病
    • 1 型糖尿病
    • 肥胖
    • 非酒精性脂肪肝
    • 其他
  • 按應用分類的市場吸引力

第 10 章：全球市場分析與預測：按地區

  • 主要發現
  • 按地區分類的市場價值、數量和患者人數預測
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 按地區分類的市場吸引力

第 11 章：北美市場分析與預測

第 12 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 公司市佔率分析 (2023)
  • Competitive Dashboard
    • By Drug Class
  • Competitive Snapshot
  • 公司簡介
    • Eli Lilly and Company
    • Sanofi SA
    • Novo Nordisk
    • AstraZeneca
    • GlaxoSmithKline
    • PegBio Co. Ltd.
    • Amgen Inc.
    • Pfizer Inc.
    • Innovent Biologics, Inc.
    • Sun Pharmaceutical Industries Limited
    • Boehringer Ingelheim
    • Biocon Limited
    • Wockhardt
Product Code: TMRGL86389

Peptide API Market - Scope of Report

TMR's report on the global peptide API market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global peptide API market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global peptide API market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the peptide API market.

Market Snapshot
Market Value in 2023US$ 9.2 Bn
Market Value in 2034US$ 94.2 Bn
CAGR22.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global peptide API market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global peptide API market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global peptide API market.

The report delves into the competitive landscape of the global peptide API market. Key players operating in the global peptide API market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global peptide API market profiled in this report.

Key Questions Answered in Global peptide API Market Report:

  • What is the sales/revenue generated by peptide API across all regions during the forecast period?
  • What are the opportunities in the global peptide API market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Peptide API Market - Research Objectives and Research Approach

The comprehensive report on the global peptide API market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global peptide API market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global peptide API market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Peptide API Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Peptide API Market Analysis and Forecasts, 2020-2034
    • 4.4.1. Market Value (US$ Bn) and Volume Projections (Kg)

5. Key Insights

  • 5.1. Epidemiology of Diabetes and Obesity across Key Countries / Regions
  • 5.2. Recent Technological Advancements in GLP-1 Receptor Agonist Therapeutics Industry
  • 5.3. Recent Technological Advancements in Insulin Therapeutics Industry
  • 5.4. GLP-1 Receptor Agonist Therapeutics Pricing Trends
  • 5.5. Insulin Therapeutics Pricing Trends
  • 5.6. Clinical Trials Analysis

6. Global Peptide API Market Analysis and Forecasts, By Drug Class

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value, Volume and Patient Population Forecast By Drug Class, 2020-2034
    • 6.3.1. GLP-1 Receptor Agonist
    • 6.3.2. Insulin
    • 6.3.3. Other Peptide Classes
  • 6.4. Market Attractiveness By Drug Class

7. Global Peptide API Market Analysis and Forecasts, By Product Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value, Volume and Patient Population Forecast By Product Type, 2020-2034
    • 7.3.1. GLP-1 Receptor Agonist Oral Formulations
    • 7.3.2. GLP-1 Receptor Agonist Injectables
    • 7.3.3. Insulin Injectables
    • 7.3.4. Other Peptides
  • 7.4. Market Attractiveness By Product Type

8. Global Peptide API Market Analysis and Forecasts, By Route of Administration

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value, Volume and Patient Population Forecast By Route of Administration, 2020-2034
    • 8.3.1. Oral
    • 8.3.2. Parenteral
  • 8.4. Market Attractiveness By Route of Administration

9. Global Peptide API Market Analysis and Forecasts, By Application

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value, Volume and Patient Population Forecast By Application, 2020-2034
    • 9.3.1. Type 2 Diabetes Mellitus
    • 9.3.2. Type 1 Diabetes
    • 9.3.3. Obesity
    • 9.3.4. Non-alcoholic Fatty Liver Disease
    • 9.3.5. Others
  • 9.4. Market Attractiveness By Application

10. Global Peptide API Market Analysis and Forecasts, By Region

  • 10.1. Key Findings
  • 10.2. Market Value, Volume and Patient Population Forecast By Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Region

11. North America Peptide API Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value, Volume and Patient Population Forecast By Drug Class, 2020-2034
    • 11.2.1. GLP-1 Receptor Agonist
    • 11.2.2. Insulin
    • 11.2.3. Other Peptide Classes
  • 11.3. Market Value, Volume and Patient Population Forecast By Product Type, 2020-2034
    • 11.3.1. GLP-1 Receptor Agonist Oral Formulations
    • 11.3.2. GLP-1 Receptor Agonist Injectables
    • 11.3.3. Insulin Injectables
    • 11.3.4. Other Peptides
  • 11.4. Market Value, Volume and Patient Population Forecast By Route of Administration, 2020-2034
    • 11.4.1. Oral
    • 11.4.2. Parenteral
  • 11.5. Market Value, Volume and Patient Population Forecast By Application, 2020-2034
    • 11.5.1. Type 2 Diabetes Mellitus
    • 11.5.2. Type 1 Diabetes
    • 11.5.3. Obesity
    • 11.5.4. Non-alcoholic Fatty Liver Disease
    • 11.5.5. Others
  • 11.6. Market Value, Volume and Patient Population Forecast By Country, 2020-2034
    • 11.6.1. U.S.
    • 11.6.2. Canada

12. Competition Landscape

  • 12.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 12.2. Market Share Analysis By Company (2023)
  • 12.3. Competitive Dashboard
    • 12.3.1. By Region
    • 12.3.2. By Drug Class
  • 12.4. Competitive Snapshot
  • 12.5. Company Profiles
    • 12.5.1. Eli Lilly and Company
      • 12.5.1.1. Company Overview
      • 12.5.1.2. Financial Overview
      • 12.5.1.3. Product Portfolio
      • 12.5.1.4. Business Strategies
      • 12.5.1.5. Recent Developments
    • 12.5.2. Sanofi S.A.
      • 12.5.2.1. Company Overview
      • 12.5.2.2. Financial Overview
      • 12.5.2.3. Product Portfolio
      • 12.5.2.4. Business Strategies
      • 12.5.2.5. Recent Developments
    • 12.5.3. Novo Nordisk
      • 12.5.3.1. Company Overview
      • 12.5.3.2. Financial Overview
      • 12.5.3.3. Product Portfolio
      • 12.5.3.4. Business Strategies
      • 12.5.3.5. Recent Developments
    • 12.5.4. AstraZeneca
      • 12.5.4.1. Company Overview
      • 12.5.4.2. Financial Overview
      • 12.5.4.3. Product Portfolio
      • 12.5.4.4. Business Strategies
      • 12.5.4.5. Recent Developments
    • 12.5.5. GlaxoSmithKline
      • 12.5.5.1. Company Overview
      • 12.5.5.2. Financial Overview
      • 12.5.5.3. Product Portfolio
      • 12.5.5.4. Business Strategies
      • 12.5.5.5. Recent Developments
    • 12.5.6. PegBio Co. Ltd.
      • 12.5.6.1. Company Overview
      • 12.5.6.2. Financial Overview
      • 12.5.6.3. Product Portfolio
      • 12.5.6.4. Business Strategies
      • 12.5.6.5. Recent Developments
    • 12.5.7. Amgen Inc.
      • 12.5.7.1. Company Overview
      • 12.5.7.2. Financial Overview
      • 12.5.7.3. Product Portfolio
      • 12.5.7.4. Business Strategies
      • 12.5.7.5. Recent Developments
    • 12.5.8. Pfizer Inc.
      • 12.5.8.1. Company Overview
      • 12.5.8.2. Financial Overview
      • 12.5.8.3. Product Portfolio
      • 12.5.8.4. Business Strategies
      • 12.5.8.5. Recent Developments
    • 12.5.9. Innovent Biologics, Inc.
      • 12.5.9.1. Company Overview
      • 12.5.9.2. Financial Overview
      • 12.5.9.3. Product Portfolio
      • 12.5.9.4. Business Strategies
      • 12.5.9.5. Recent Developments
    • 12.5.10. Sun Pharmaceutical Industries Limited
      • 12.5.10.1. Company Overview
      • 12.5.10.2. Financial Overview
      • 12.5.10.3. Product Portfolio
      • 12.5.10.4. Business Strategies
      • 12.5.10.5. Recent Developments
    • 12.5.11. Boehringer Ingelheim
      • 12.5.11.1. Company Overview
      • 12.5.11.2. Financial Overview
      • 12.5.11.3. Product Portfolio
      • 12.5.11.4. Business Strategies
      • 12.5.11.5. Recent Developments
    • 12.5.12. Biocon Limited
      • 12.5.12.1. Company Overview
      • 12.5.12.2. Financial Overview
      • 12.5.12.3. Product Portfolio
      • 12.5.12.4. Business Strategies
      • 12.5.12.5. Recent Developments
    • 12.5.13. Wockhardt
      • 12.5.13.1. Company Overview
      • 12.5.13.2. Financial Overview
      • 12.5.13.3. Product Portfolio
      • 12.5.13.4. Business Strategies
      • 12.5.13.5. Recent Developments

Peptide API Market

Peptide API Industry

Peptide API Market Size

Peptide API Market Share

Peptide API Market Growth

Peptide API Market Analysis

Peptide API Market Demand

Peptide API Market Forecast

Peptide API Market Trends

List of Tables

  • Table 01: Global Peptide API Market Value (US$ Bn) Forecast, by Drug Class, 2020-2034
  • Table 02: Global Peptide API Market Volume (Kg) Forecast, by Drug Class, 2020-2034
  • Table 03: Global Peptide API Market, by Drug Class (Patient Population) (Bn), 2020-2034
  • Table 04: Global Peptide API Market Value (US$ Bn) Forecast, by Product Type, 2020-2034
  • Table 05: Global Peptide API Market Volume (Kg) Forecast, by Product Type, 2020-2034
  • Table 06: Global Peptide API Market, Product Type (Patient Population) (Bn), 2020-2034
  • Table 07: Global Peptide API Market Value (US$ Bn) Forecast, by Route of Administration, 2020-2034
  • Table 08: Global Peptide API Market Volume (Kg) Forecast, by Route of Administration, 2020-2034
  • Table 09: Global Peptide API Market, by Route of Administration (Patient Population) (Bn), 2020-2034
  • Table 10: Global Peptide API Market Value (US$ Bn) Forecast, by Application, 2020-2034
  • Table 11: Global Peptide API Market Volume (Kg) Forecast, by Application, 2020-2034
  • Table 12: Global Peptide API Market, by Application (Patient Population) (Bn), 2020-2034
  • Table 13: Global Peptide API Market Value (US$ Bn) Forecast, by Region, 2020-2034
  • Table 14: Global Peptide API Market Volume (Kg) Forecast, by Region, 2020-2034
  • Table 15: Global Peptide API Market, by Region (Patient Population) (Bn), 2020-2034
  • Table 16: North America Peptide API Market Value (US$ Bn) Forecast, by Country, 2020-2034
  • Table 17: North America Peptide API Market Volume (Kg) Forecast, by Country, 2020-2034
  • Table 18: North America Peptide API Market, (Patient Population) (Bn) 2020-2034
  • Table 19: North America Peptide API Market Value (US$ Bn) Forecast, by Drug Class, 2020-2034
  • Table 20: North America Peptide API Market Volume (Kg) Forecast, by Drug Class, 2020-2034
  • Table 21: North America Peptide API Market, by Drug Class (Patient Population) (Bn), 2020-2034
  • Table 22: North America Peptide API Market Value (US$ Bn) Forecast, by Product Type, 2020-2034
  • Table 23: North America Peptide API Market Volume (Kg) Forecast, by Product Type, 2020-2034
  • Table 24: North America Peptide API Market, Product Type (Patient Population) (Bn), 2020-2034
  • Table 25: North America Peptide API Market Value (US$ Bn) Forecast, by Route of Administration, 2020-2034
  • Table 26: North America Peptide API Market Volume (Kg) Forecast, by Route of Administration, 2020-2034
  • Table 27: North America Peptide API Market, by Route of Administration (Patient Population) (Bn), 2020-2034
  • Table 28: North America Peptide API Market Volume (Kg) Forecast, by Application, 2020-2034
  • Table 29: North America Peptide API Market Volume (Kg) Forecast, by Application, 2020-2034
  • Table 30: North America Peptide API Market, by Application (Patient Population) (Bn), 2020-2034

List of Figures

  • Figure 01: Global Peptide API Market Value (US$ Bn) Forecast, 2020-2034
  • Figure 02: Global Peptide API Market Value Share, by Drug Class, 2023
  • Figure 03: Global Peptide API Market Value Share, by Product Type, 2023
  • Figure 04: Global Peptide API Market Value Share, by Route of Administration, 2023
  • Figure 05: Global Peptide API Market Value Share, by Application, 2023
  • Figure 06: Global Peptide API Market Value Share, by Region, 2023
  • Figure 07: Global Peptide API Market Value (US$ Bn) Share Analysis, by Drug Class, 2023 and 2034
  • Figure 08: Global Peptide API Market Share Analysis, by Drug Class, 2023
  • Figure 09: Global Peptide API Market Share Analysis, by Drug Class, 2034
  • Figure 10: Global Peptide API Market Volume (Kg) Share Analysis, by Drug Class, 2023 and 2034
  • Figure 11: Global Peptide API Market Share Analysis, by Drug Class, 2023
  • Figure 12: Global Peptide API Market Share Analysis, by Drug Class, 2034
  • Figure 13: Global Peptide API Market Attractiveness Analysis, by Drug Class, 2024-2034
  • Figure 14: Global Peptide API Market Value (US$ Bn), by GLP-1 Receptor Agonist, 2020-2034
  • Figure 15: Global Peptide API Market Value Share Analysis, by GLP-1 Receptor Agonist, 2023 and 2034
  • Figure 16: Global Peptide API Market Value (US$ Bn), by Insulin, 2020-2034
  • Figure 17: Global Peptide API Market Value Share Analysis, by Insulin, 2023 and 2034
  • Figure 18: Global Peptide API Market Value (US$ Bn), by Other Peptide Classes, 2020-2034
  • Figure 19: Global Peptide API Market Value Share Analysis, by Other Peptide Classes, 2023 and 2034
  • Figure 20: Global Peptide API Market Volume (Kg), by GLP-1 Receptor Agonist, 2020-2034
  • Figure 21: Global Peptide API Market Volume Share Analysis, by GLP-1 Receptor Agonist, 2023 and 2034
  • Figure 22: Global Peptide API Market Volume (Kg), by Insulin, 2020-2034
  • Figure 23: Global Peptide API Market Volume Share Analysis, by Insulin, 2023 and 2034
  • Figure 24: Global Peptide API Market Volume (Kg), by Other Peptide Classes, 2020-2034
  • Figure 25: Global Peptide API Market Volume Share Analysis, by Other Peptide Classes, 2023 and 2034
  • Figure 26: Global Peptide API Market Value (US$ Bn) Share Analysis, by Product Type, 2023 and 2034
  • Figure 27: Global Peptide API Market Share Analysis, by Product Type, 2023
  • Figure 28: Global Peptide API Market Share Analysis, by Product Type, 2034
  • Figure 29: Global Peptide API Market Volume (Kg) Share Analysis, by Product Type, 2023 and 2034
  • Figure 30: Global Peptide API Market Share Analysis, by Product Type, 2023
  • Figure 31: Global Peptide API Market Share Analysis, by Product Type, 2034
  • Figure 32: Global Peptide API Market Attractiveness Analysis, by Product Type, 2024-2034
  • Figure 33: Global Peptide API Market Value (US$ Bn), by GLP-1 Receptor Agonist Oral Formulations, 2020-2034
  • Figure 34: Global Peptide API Market Value Share Analysis, by GLP-1 Receptor Agonist Oral Formulations, 2023 and 2034
  • Figure 35: Global Peptide API Market Value (US$ Bn), by GLP-1 Receptor Agonist Injectable, 2020-2034
  • Figure 36: Global Peptide API Market Value Share Analysis, by GLP-1 Receptor Agonist Injectables, 2023 and 2034
  • Figure 37: Global Peptide API Market Value (US$ Bn), by Insulin Injectables, 2020-2034
  • Figure 38: Global Peptide API Market Value Share Analysis, by Insulin Injectables, 2023 and 2034
  • Figure 39: Global Peptide API Market Value (US$ Bn), by Other Peptides, 2020-2034
  • Figure 40: Global Peptide API Market Value Share Analysis, by Other Peptides, 2023 and 2034
  • Figure 41: Global Peptide API Market Volume (Kg), by GLP-1 Receptor Agonist Oral Formulations, 2020-2034
  • Figure 42: Global Peptide API Market Value Share Analysis, by GLP-1 Receptor Agonist Oral Formulations, 2023 and 2034
  • Figure 43: Global Peptide API Market Volume (Kg), by GLP-1 Receptor Agonist Injectable, 2020-2034
  • Figure 44: Global Peptide API Market Value Share Analysis, by GLP-1 Receptor Agonist Injectables, 2023 and 2034
  • Figure 45: Global Peptide API Market Volume (Kg), by Insulin Injectables, 2020-2034
  • Figure 46: Global Peptide API Market Value Share Analysis, by Insulin Injectables, 2023 and 2034
  • Figure 47: Global Peptide API Market Volume (Kg), by Other Peptides, 2020-2034
  • Figure 48: Global Peptide API Market Value Share Analysis, by Other Peptides, 2023 and 2034
  • Figure 49: Global Peptide API Market Value (US$ Bn) Share Analysis, by Route of Administration, 2023 and 2034
  • Figure 50: Global Peptide API Market Share Analysis, by Route of Administration, 2023
  • Figure 51: Global Peptide API Market Share Analysis, by Route of Administration, 2034
  • Figure 52: Global Peptide API Market Volume (Kg) Share Analysis, by Route of Administration, 2023 and 2034
  • Figure 53: Global Peptide API Market Share Analysis, by Route of Administration, 2023
  • Figure 54: Global Peptide API Market Share Analysis, by Route of Administration, 2034
  • Figure 55: Global Peptide API Market Attractiveness Analysis, by Route of Administration, 2024-2034
  • Figure 56: Global Peptide API Market Value (US$ Bn), by Oral, 2020-2034
  • Figure 57: Global Peptide API Market Value Share Analysis, by Oral, 2023 and 2034
  • Figure 58: Global Peptide API Market Value (US$ Bn), by Parenteral, 2020-2034
  • Figure 59: Global Peptide API Market Value Share Analysis, by Parenteral, 2023 and 2034
  • Figure 60: Global Peptide API Market Volume (Kg), by Oral, 2020-2034
  • Figure 61: Global Peptide API Market Value Share Analysis, by Oral, 2023 and 2034
  • Figure 62: Global Peptide API Market Volume (Kg), by Parenteral, 2020-2034
  • Figure 63: Global Peptide API Market Value Share Analysis, by Parenteral, 2023 and 2034
  • Figure 64: Global Peptide API Market Value (US$ Bn) Share Analysis, by Application, 2023 and 2034
  • Figure 65: Global Peptide API Market Share Analysis, by Application, 2023
  • Figure 66: Global Peptide API Market Share Analysis, by Application, 2034
  • Figure 67: Global Peptide API Market Volume (Kg) Share Analysis, by Application, 2023 and 2034
  • Figure 68: Global Peptide API Market Share Analysis, by Application, 2023
  • Figure 69: Global Peptide API Market Share Analysis, by Application, 2034
  • Figure 70: Global Peptide API Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 71: Global Peptide API Market Value (US$ Bn), by Type 2 Diabetes Mellitus, 2020-2034
  • Figure 72: Global Peptide API Market Value Share Analysis, by Type 2 Diabetes Mellitus, 2023 and 2034
  • Figure 73: Global Peptide API Market Value (US$ Bn), by Type 1 Diabetes, 2020-2034
  • Figure 74: Global Peptide API Market Value Share Analysis, by Type 1 Diabetes, 2023 and 2034
  • Figure 75: Global Peptide API Market Value (US$ Bn), by Obesity, 2020-2034
  • Figure 76: Global Peptide API Market Value Share Analysis, by Obesity, 2023 and 2034
  • Figure 77: Global Peptide API Market Value (US$ Bn), by Non-alcoholic Fatty Liver Disease, 2020-2034
  • Figure 78: Global Peptide API Market Value Share Analysis, by Non-alcoholic Fatty Liver Disease, 2023 and 2034
  • Figure 79: Global Peptide API Market Value (US$ Bn), by Others, 2020-2034
  • Figure 80: Global Peptide API Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 81: Global Peptide API Market Volume (Kg), by Type 2 Diabetes Mellitus, 2020-2034
  • Figure 82: Global Peptide API Market Value Share Analysis, by Type 2 Diabetes Mellitus, 2023 and 2034
  • Figure 83: Global Peptide API Market Volume (Kg), by Type 1 Diabetes, 2020-2034
  • Figure 84: Global Peptide API Market Value Share Analysis, by Type 1 Diabetes, 2023 and 2034
  • Figure 85: Global Peptide API Market Volume (Kg), by Obesity, 2020-2034
  • Figure 86: Global Peptide API Market Value Share Analysis, by Obesity, 2023 and 2034
  • Figure 87: Global Peptide API Market Volume (Kg), by Non-alcoholic Fatty Liver Disease, 2020-2034
  • Figure 88: Global Peptide API Market Value Share Analysis, by Non-alcoholic Fatty Liver Disease, 2023 and 2034
  • Figure 89: Global Peptide API Market Volume (Kg), by Others, 2020-2034
  • Figure 90: Global Peptide API Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 91: Global Peptide API Market Value (US$ Bn) Share Analysis, by Region, 2023 and 2034
  • Figure 92: Global Peptide API Market Share Analysis, by Region, 2023
  • Figure 93: Global Peptide API Market Share Analysis, by Region, 2034
  • Figure 94: Global Peptide API Market Volume (Kg) Share Analysis, by Region, 2023 and 2034
  • Figure 95: Global Peptide API Market Share Analysis, by Region, 2023
  • Figure 96: Global Peptide API Market Share Analysis, by Region, 2034
  • Figure 97: Global Peptide API Market Attractiveness Analysis, by Region, 2023-2034
  • Figure 98: North America Peptide API Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 99: North America Peptide API Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 100: North America Peptide API Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 101: North America Peptide API Market Volume (Kg) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 102: North America Peptide API Market Volume Share Analysis, by Country, 2023 and 2034
  • Figure 103: North America Peptide API Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 104: North America Peptide API Market Value (US$ Bn) Share Analysis, by Drug Class, 2023 and 2034
  • Figure 105: North America Peptide API Market Attractiveness Analysis, by Drug Class, 2024-2034
  • Figure 106: North America Peptide API Market Volume (Kg) Share Analysis, by Drug Class, 2023 and 2034
  • Figure 107: North America Peptide API Market Attractiveness Analysis, by Drug Class, 2024-2034
  • Figure 108: North America Peptide API Market Value (US$ Bn) Share Analysis, by Product Type, 2023 and 2034
  • Figure 109: North America Peptide API Market Attractiveness Analysis, by Product Type, 2024-2034
  • Figure 110: North America Peptide API Market Volume (Kg) Share Analysis, by Product Type, 2023 and 2034
  • Figure 111: North America Peptide API Market Attractiveness Analysis, by Product Type, 2024-2034
  • Figure 112: North America Peptide API Market Value (US$ Bn) Share Analysis, by Route of Administration, 2023 and 2034
  • Figure 113: North America Peptide API Market Attractiveness Analysis, by Route of Administration, 2024-2034
  • Figure 114: North America Peptide API Market Volume (Kg) Share Analysis, by Route of Administration, 2023 and 2034
  • Figure 115: North America Peptide API Market Attractiveness Analysis, by Route of Administration, 2024-2034
  • Figure 116: North America Peptide API Market Value (US$ Bn) Share Analysis, by Application, 2023 and 2034
  • Figure 117: North America Peptide API Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 118: North America Peptide API Market Volume (Kg) Share Analysis, by Application, 2023 and 2034
  • Figure 119: North America Peptide API Market Attractiveness Analysis, by Application, 2024-2034